Evolutionary epidemiology of drug-resistance in space.

How can we optimize the use of drugs against parasites to limit the evolution of drug resistance? This question has been addressed by many theoretical studies focusing either on the mixing of various treatments, or their temporal alternation. Here we consider a different treatment strategy where the...

Full description

Bibliographic Details
Main Authors: Florence Débarre, Thomas Lenormand, Sylvain Gandon
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2009-04-01
Series:PLoS Computational Biology
Online Access:http://europepmc.org/articles/PMC2658742?pdf=render
id doaj-be47087a55bf4b419f1b1712acfeeb80
record_format Article
spelling doaj-be47087a55bf4b419f1b1712acfeeb802020-11-25T01:13:12ZengPublic Library of Science (PLoS)PLoS Computational Biology1553-734X1553-73582009-04-0154e100033710.1371/journal.pcbi.1000337Evolutionary epidemiology of drug-resistance in space.Florence DébarreThomas LenormandSylvain GandonHow can we optimize the use of drugs against parasites to limit the evolution of drug resistance? This question has been addressed by many theoretical studies focusing either on the mixing of various treatments, or their temporal alternation. Here we consider a different treatment strategy where the use of the drug may vary in space to prevent the rise of drug-resistance. We analyze epidemiological models where drug-resistant and drug-sensitive parasites compete in a one-dimensional spatially heterogeneous environment. Two different parasite life-cycles are considered: (i) direct transmission between hosts, and (ii) vector-borne transmission. In both cases we find a critical size of the treated area, under which the drug-resistant strain cannot persist. This critical size depends on the basic reproductive ratios of each strain in each environment, on the ranges of dispersal, and on the duration of an infection with drug-resistant parasites. We discuss optimal treatment strategies that limit disease prevalence and the evolution of drug-resistance.http://europepmc.org/articles/PMC2658742?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Florence Débarre
Thomas Lenormand
Sylvain Gandon
spellingShingle Florence Débarre
Thomas Lenormand
Sylvain Gandon
Evolutionary epidemiology of drug-resistance in space.
PLoS Computational Biology
author_facet Florence Débarre
Thomas Lenormand
Sylvain Gandon
author_sort Florence Débarre
title Evolutionary epidemiology of drug-resistance in space.
title_short Evolutionary epidemiology of drug-resistance in space.
title_full Evolutionary epidemiology of drug-resistance in space.
title_fullStr Evolutionary epidemiology of drug-resistance in space.
title_full_unstemmed Evolutionary epidemiology of drug-resistance in space.
title_sort evolutionary epidemiology of drug-resistance in space.
publisher Public Library of Science (PLoS)
series PLoS Computational Biology
issn 1553-734X
1553-7358
publishDate 2009-04-01
description How can we optimize the use of drugs against parasites to limit the evolution of drug resistance? This question has been addressed by many theoretical studies focusing either on the mixing of various treatments, or their temporal alternation. Here we consider a different treatment strategy where the use of the drug may vary in space to prevent the rise of drug-resistance. We analyze epidemiological models where drug-resistant and drug-sensitive parasites compete in a one-dimensional spatially heterogeneous environment. Two different parasite life-cycles are considered: (i) direct transmission between hosts, and (ii) vector-borne transmission. In both cases we find a critical size of the treated area, under which the drug-resistant strain cannot persist. This critical size depends on the basic reproductive ratios of each strain in each environment, on the ranges of dispersal, and on the duration of an infection with drug-resistant parasites. We discuss optimal treatment strategies that limit disease prevalence and the evolution of drug-resistance.
url http://europepmc.org/articles/PMC2658742?pdf=render
work_keys_str_mv AT florencedebarre evolutionaryepidemiologyofdrugresistanceinspace
AT thomaslenormand evolutionaryepidemiologyofdrugresistanceinspace
AT sylvaingandon evolutionaryepidemiologyofdrugresistanceinspace
_version_ 1725162992963682304